High-Frequency Chest Wall Oscillation (HFCWO)
HFCWO, commonly known as "Vest Therapy," has evolved in 2026 into a more mobile and "wearable" technology.
The SmartVest® and Monarch™ Systems: Unlike older stationary units, 2026 models like the Monarch utilize battery-powered "pulmonary oscillators" integrated directly into the vest. This allows patients to move freely or even perform light chores while receiving therapy.
360° Compression: High-end systems now provide 360-degree chest coverage, delivering rapid pulses of air that gently squeeze and release the chest wall. This creates "cough-like" shear forces within the small airways, mobilizing secretions toward the central airways for expectoration.
Clinical Necessity: By 2026, HFCWO is considered "medically necessary" by major insurers for patients with CF or neuromuscular disorders (like ALS or MS) who lack the muscle strength to produce an effective natural cough.
